Transcriptional profiling of the host cell response to feline immunodeficiency virus infection

Virology Journal

Volumn 11, Issue 1, 2014, Pages

  Ertl, Reinhard ^a   Klein, Dieter ^a  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

Feline immunodeficiency virus; Host cell response; Transcriptome sequencing; Virus host interactions

Indexed keywords

TRANSCRIPTOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CAT DISEASE; CONTROLLED STUDY; DOWN REGULATION; FELINE IMMUNODEFICIENCY VIRUS INFECTION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SEQUENCE; GENOME; HOST CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; RETROVIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; UPREGULATION; VIRION; VIRUS CELL INTERACTION; VIRUS PARTICLE; VIRUS REPLICATION;

ANIMALS; CATS; GENE EXPRESSION PROFILING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HOST-PATHOGEN INTERACTIONS; IMMUNODEFICIENCY VIRUS, FELINE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTOME;

EID: 84899460108     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-11-52     Document Type: Article

References (44)

1. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Pedersen NC, Ho EW, Brown ML, Yamamoto JK, Science 1987 235 790 793 10.1126/science.3643650 3643650
2. Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV. Elder JH, Lin YC, Fink E, Grant CK, Curr HIV Res 2010 8 73 80 10.2174/157016210790416389 20210782
3. Natural transmission of feline immunodeficiency virus from infected queen to kitten. Medeiros SDO, Martins AN, Dias CGA, Tanuri A, Brindeiro RDM, Virol J 2012 9 99 10.1186/1743-422X-9-99 22632459
4. Clinical aspects of feline immunodeficiency and feline leukemia virus infection. Hartmann K, Vet Immunol Immunopathol 2011 143 190 201 10.1016/j.vetimm.2011.06.003 21807418
5. The molecular biology of feline immunodeficiency virus (FIV). Kenyon JC, Lever AM, Viruses 2011 3 2192 2213 10.3390/v3112192 22163340
6. Microarray data on gene modulation by HIV-1 in immune cells: 2000-2006. Giri MS, Nebozhyn M, Showe L, Montaner LJ, J Leukocyte Biol 2006 80 1031 1043 10.1189/jlb.0306157 16940334
7. Gene-expression changes induced by Feline immunodeficiency virus infection differ in epithelial cells and lymphocytes. Dowling RJO, Bienzle D, J Gen Virol 2005 86 2239 2248 10.1099/vir.0.80735-0 16033971
8. Feline immunodeficiency virus OrfA alters gene expression of splicing factors and proteasome-ubiquitination proteins. Sundstrom M, Chatterji U, Schaffer L, de Rozières S, Elder JH, Virology 2008 371 394 404 10.1016/j.virol.2007.09.039 17963812
9. Application of next-generation sequencing technologies in virology. Radford AD, Chapman D, Dixon L, Chantrey J, Darby AC, Hall N, J Gen Virol 2012 2012 1853 1868
10. Quantification using real-time PCR technology: Applications and limitations. Klein D, Trends Mol Med 2002 8 257 260 10.1016/S1471-4914(02)02355- 9 12067606
11. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B, Nat Methods 2008 5 621 628 10.1038/nmeth.1226 18516045
12. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Benjamini Y, Hochberg Y, J R Stat Soc Series B Stat Methodol 1995 57 289 300
13. High-throughput DNA methylation datasets for evaluating false discovery rate methodologies. Asomaning N, Archer KJ, Comput Stat Data Anal 2012 56 1748 1756 10.1016/j.csda.2011.10.020 22611297
14. Differential expression in RNA-seq: A matter of depth. Tarazona S, García-Alcalde F, Dopazo J, Ferrer A, Conesa A, Genome Res 2011 21 2213 2223 10.1101/gr.124321.111 21903743
15. 2′,5′-Oligoadenylate synthetase-like gene highly induced by hepatitis C virus infection in human liver is inhibitory to viral replication in vitro. Ishibashi M, Wakita T, Esumi M, Biochem Biophys Res Commun 2010 392 397 402 10.1016/j.bbrc.2010.01.034 20074559
16. Differential regulation of the OASL and OAS1 genes in response to viral infections. Melchjorsen J, Kristiansen H, Christiansen R, Rintahaka J, Matikainen S, Paludan SR, Hartmann R, J Interferon Cytokine Res 2009 29 199 207 10.1089/jir.2008.0050 19203244
17. RNA helicases in infection and disease. Steimer L, Klostermeier D, RNA Biol 2012 9 751 771 10.4161/rna.20090 22699555
18. Genetic characterization of HIV type 1 nef-induced vesicle secretion. Ali SA, Huang MB, Campbell PE, Roth WW, Campbell T, Khan M, Newman G, Villinger F, Powell MD, Bond VC, AIDS Res Hum Retroviruses 2010 26 173 192 10.1089/aid.2009.0068 20156100
19. Induction of tissue transglutaminase in HIV pathogenesis: evidence for high rate of apoptosis of CD4+ T lymphocytes and accessory cells in lymphoid tissues. Amendola A, Gougeon ML, Poccia F, Bondurand A, Fesus L, Piacentini M, Proc Natl Acad Sci U S A 1996 93 11057 11062 10.1073/pnas.93.20.11057 8855308
20. "Tissue" Transglutaminase Expression in HIV-Infected Cells. Amendola A, Rodolfo C, Caro A, Ciccosanti F, Falasca L, Piacentini M, Ann N Y Acad Sci 2001 946 108 120 11762979
21. Identification of cellular factors binding to acetylated HIV-1 integrase. Allouch A, Cereseto A, Amino Acids 2011 41 1137 1145 10.1007/s00726-009-0444-3 20016921
22. Effect of HIV-1 Vpr on cell cycle regulators. Amini S, Khalili K, Sawaya BE, DNA Cell Biol 2004 23 249 260 10.1089/104454904773819833 15142382
23. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Goh WC, Rogel ME, Kinsey CM, Michael SF, Fultz PN, Nowak MA, Hahn BH, Emerman M, Nature Med 1998 4 65 71 10.1038/nm0198-065 9427608
24. Tristetraprolin inhibits HIV-1 production by binding to genomic RNA. Maeda M, Sawa H, Tobiume M, Tokunaga K, Hasegawa H, Ichinohe T, Sata T, Moriyama M, Hall WW, Kurata T, Takahashi H, Microb Infect 2006 8 2647 2656 10.1016/j.micinf.2006.07.010
25. BCL6 can repress transcription from the human immunodeficiency virus type I promoter/enhancer region. Baron BW, Desai M, Julia Baber L, Paras L, Zhang Q, Sadhu A, Duguay S, Nucifora G, McKeithan TW, Zeleznik-Le N, Genes Chromosomes Cancer 1997 19 14 21 10.1002/(SICI)1098-2264(199705)19:1<14::AID-GCC3>3.0. CO;2-3 9135990
26. Apoptotic killing of HIV-1-infected macrophages is subverted by the viral envelope glycoprotein. Swingler S, Mann AM, Zhou J, Swingler C, Stevenson M, PLoS Pathog 2007 3 1281 1290 17907802
27. HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages. Izmailova E, Bertley FM, Huang Q, Makori N, Miller CJ, Young RA, Aldovini A, Nat Med 2003 9 191 197 10.1038/nm822 12539042
28. Antiproliferative activity of the human IFN-inducible protein IFI44. Hallen LC, Burki Y, Ebeling M, Broger C, Siegrist F, Oroszlan-Szovik K, Bohrmann B, Certa U, Foser S, J Interferon Cytokine Res 2007 27 675 680 10.1089/jir.2007.0021 17784819
29. Cellular heat shock factor 1 positively regulates human immunodeficiency virus-1 gene expression and replication by two distinct pathways. Rawat P, Mitra D, Nucleic Acids Res 2011 39 5879 5892 10.1093/nar/gkr198 21459854
30. Roles for CXC chemokine ligands 10 and 11 in recruiting CD4+ T cells to HIV-1-infected monocyte-derived macrophages, dendritic cells, and lymph nodes. Foley JF, Yu CR, Solow R, Yacobucci M, Peden KW, Farber JM, J Immunol 2005 174 4892 4900 15814716
31. Inhibition of SIRT1 by HIV-1 viral protein Tat results in activation of p53 pathway. Thakur BK, Chandra A, Dittrich T, Welte K, Chandra P, Biochem Biophys Res Commun 2012 424 245 25 10.1016/j.bbrc.2012.06.084 22732402
32. HIV-1-Tat protein activates phosphatidylinositol 3-kinase/AKT-dependent survival pathways in Kaposi's sarcoma cells. Deregibus MC, Cantaluppi V, Doublier S, Brizzi MF, Deambrosis I, Albini A, Camussi G, J Biol Chem 2002 277 25195 25202 10.1074/jbc.M200921200 11994280
33. The global gene-expression profiles of U-937 human macrophages treated with Tat peptide and Tat-FITC conjugate. Lin CW, Kuo JHS, Jan MS, J Drug Target 2012 20 515 523 10.3109/1061186X.2012.693496 22632162
34. HIV-1 Tat protein directly induces mitochondrial membrane permeabilization and inactivates cytochrome c oxidase. Lecoeur H, Borgne-Sanchez A, Chaloin O, El-Khoury R, Brabant M, Langonné A, Porceddu M, Briere JJ, Buron N, Rebouillat D, Péchoux C, Deniaud A, Brenner C, Briand JP, Muller S, Rustin P, Jacotot E, Cell Death Dis 2012 3 282 10.1038/cddis.2012.21 22419111
35. HIV-1 Vpr activates cell cycle inhibitor p21/Waf1/Cip1: A potential mechanism of G2/M cell cycle arrest. Chowdhury IH, Wang XF, Landau NR, Robb ML, Polonis VR, Birx DL, Kim JH, Virology 2003 305 371 377 10.1006/viro.2002.1777 12573582
36. Molecular cloning of feline immunodeficiency virus. Olmsted RA, Barnes AK, Yamamoto JK, Hirsch VM, Purcell RH, Johnson PR, Proc Natl Acad Sci U S A 1989 86 2448 2452 10.1073/pnas.86.7.2448 2928341
37. Viral transcriptome analysis of feline immunodeficiency virus infected cells using second generation sequencing technology. Ertl R, Birzele F, Hildebrandt T, Klein D, Vet Immunol Immunopathol 2011 143 314 324 10.1016/j.vetimm.2011.06.010 21742384
38. Influence of preassay and sequence variations on viral load determination by a multiplex read-time reverse transcriptase-polymerase chain reaction for feline immunodeficiency virus. Klein D, Leutenegger CM, Bahula C, Gold P, Hofmann-Lehmann R, Salmons B, Lutz H, Gunzburg WH, J Acquir Immune Defic Syndr 2001 26 8 20 10.1097/00126334-200101010-00002 11176264
39. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. O'Doherty U, Swiggard WJ, Malim MH, J Virol 2000 74 10074 10080 10.1128/JVI.74.21.10074-10080.2000 11024136
40. Structure and transcription of a human gene for H1 RNA, the RNA component of human RNase P. Baer M, Nilsen TW, Costigan C, Altman S, Nucleic Acids Res 1990 18 97 103 10.1093/nar/18.1.97 2308839
41. RobiNA: A user-friendly, integrated software solution for RNA-Seq-based transcriptomics. Lohse M, Bolger AM, Nagel A, Fernie AR, Lunn JE, Stitt M, Usadel B, Nucleic Acids Res 2012 40 622 W627 10.1093/nar/gks540 22684630
42. Proviral load determination of different feline immunodeficiency virus isolates using real-time polymerase chain reaction: Influence of mismatches on quantification. Klein D, Janda P, Steinborn R, Müller M, Salmons B, Günzburg WH, Electrophoresis 1999 20 291 299 10.1002/(SICI)1522- 2683(19990201)20:2<291::AID-ELPS291>3.0.CO;2-R 10197436
43. Quantitative TaqMan® real-time PCR assays for gene expression normalisation in feline tissues. Kessler Y, Helfer-Hungerbuehler AK, Cattori V, Meli M, Zellweger B, Ossent P, Riond B, Reusch CE, Lutz H, Hofmann-Lehmann R, BMC Mol Biol 2009 10 106 10.1186/1471-2199-10-106 20003366
44. Analysis of relative gene expression data using real-time quantitative PCR and the 2ΔΔCT method. Livak KJ, Schmittgen TD, Methods 2001 25 402 408 10.1006/meth.2001.1262 11846609